Modeling the consequences of recurrences after trastuzumab treatment of HER2+ early-stage breast cancer.

e12032Background: The study objective was to estimate the long-term consequences of recurrences following treatment with trastuzumab (TRA) among women with HER2+ early stage breast cancer (BC) in t...